Who owns APREA THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Aprea Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Aprea Therapeutics stock

Who bought or sold APREA THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
AIGH Capital Management 539k $3.5M 54% Mar 2024
 View chart
Sio Capital Management 277k $1.9M -1% Mar 2024
 View chart
Sphera Funds Management 270k $1.8M 100% Mar 2024
 View chart
Nantahala Capital Management 206k $1.4M 100% Mar 2024
 View chart
DAFNA Capital Management 137k $918k 100% Mar 2024
 View chart
Vanguard Group 116k $776k 234% Mar 2024
 View chart
Morgan Stanley 27k $179k 84% Mar 2024
 View chart
Geode Capital Management 20k $135k 16% Mar 2024
 View chart
HighTower Advisors 14k $93k 100% Mar 2024
 View chart
BlackRock 8.5k $57k -8% Mar 2024
 View chart
Royal Bank of Canada 2.6k $17k -94% Mar 2024
 View chart
Group One Trading 2.2k $14k 0% Mar 2024
 View chart
Bank of America Corporation 1.6k $11k -52% Mar 2024
 View chart
Tower Research Capital 1.1k $7.5k -36% Mar 2024
 View chart
Pnc Financial Services 1.0k $6.7k 0% Mar 2024
 View chart
Advisor Group Holdings 300.00 $2.0k 50% Mar 2024
 View chart
Wells Fargo & Company 272.00 $1.8k 0% Mar 2024
 View chart
FMR 161.00 $1.1k 100% Mar 2024
 View chart
WealthCollab 158.00 $1.1k 0% Mar 2024
 View chart
Old Point Trust & Financial Services N A 50.00 $335.000000 100% Mar 2024
 View chart
UBS Group 3.00 $20.000100 0% Mar 2024
 View chart

Who sold out of Aprea Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Susquehanna International Sep 2023 104k $437k
Worth Venture Partners Dec 2023 87k $410k
Walleye Trading Advisors Dec 2023 80k $376k
Jpmorgan Chase & Co Dec 2023 5.00 $24.000000